ATP5ME
ATP synthase F(0) complex subunit e, mitochondrial
Also known as: ATP5I, ATP5I_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56385
- Gene
- ATP5ME
- Ensembl
- ENSG00000169020
- Chromosome
- 4
- Canonical length
- 69 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. It is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel. The F1 complex consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled in a ratio of 3 alpha, 3 beta, and a single representative of the other 3. The Fo seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the e subunit of the Fo complex. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
69 residues, UniProt reviewed canonical sequence.
>P56385|ATP5ME
1 MVPPVQVSPL IKLGRYSALF LGVAYGATRY NYLKPRAEEE RRIAAEEKKK QDELKRIARE
61 LAEDDSILKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5ME can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 2,121 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 2,121 nTPM
- skeletal muscle: 1,922 nTPM
- tongue: 1,574 nTPM
- choroid plexus: 1,284 nTPM
- midbrain: 1,092 nTPM
- amygdala: 1,039 nTPM
Single-cell type
- parietal cells: 4,662 nCPM
- hepatocytes: 3,037 nCPM
- enterocytes: 2,036 nCPM
- colonocytes: 1,506 nCPM
- enteric transient amplifying cells: 1,306 nCPM
- gastric chief cells: 1,208 nCPM
Immune cell
- memory B-cell: 1,480 nTPM
- total PBMC: 1,465 nTPM
- eosinophil: 1,196 nTPM
- plasmacytoid DC: 1,186 nTPM
- naive B-cell: 1,141 nTPM
- T-reg: 1,091 nTPM
Brain region
- white matter: 349 nTPM
- cerebellum: 327 nTPM
- medulla oblongata: 325 nTPM
- pons: 307 nTPM
- hypothalamus: 298 nTPM
- thalamus: 281 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5ME.
Disease | ImmuneIEDB
Conditions an epitope on ATP5ME was assayed in.
- sarcoidosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0.09
- DepMap mean gene effect
- -0.43
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP synthase, F0 complex, subunit E, mitochondrial
- ATP synthase E chain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5ME in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5ME as an antibody target. Whether an autoantibody or antibody against ATP5ME could matter depends on whether native ATP5ME is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5ME is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5ME as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...